{"id":"https://openalex.org/W1978773847","doi":"https://doi.org/10.1080/07853890903186168","title":"The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients","display_name":"The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W1978773847","doi":"https://doi.org/10.1080/07853890903186168","mag":"1978773847","pmid":"https://pubmed.ncbi.nlm.nih.gov/19711211"},"language":"en","primary_location":{"id":"doi:10.1080/07853890903186168","doi":"https://doi.org/10.1080/07853890903186168","is_oa":true,"landing_page_url":"https://doi.org/10.1080/07853890903186168","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/07853890903186168?needAccess=true","source":{"id":"https://openalex.org/S203391715","display_name":"Annals of Medicine","issn_l":"0785-3890","issn":["0785-3890","1365-2060"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/07853890903186168?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077170941","display_name":"Milka Hauta\u2010aho","orcid":"https://orcid.org/0000-0002-8210-9274","observed_orcids":["https://orcid.org/0000-0002-8210-9274"]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Milka Hauta-Aho","raw_affiliation_strings":["Department of Pharmacology, Drug Development, and Therapeutics, University of Turku, Turku, Finland. mehaah@utu.fi","Department of Pharmacology, Drug Development, and Therapeutics, University of Turku, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Drug Development, and Therapeutics, University of Turku, Turku, Finland. mehaah@utu.fi","institution_ids":["https://openalex.org/I155660961"]},{"raw_affiliation_string":"Department of Pharmacology, Drug Development, and Therapeutics, University of Turku, Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045429821","display_name":"Tuire Prami","orcid":"https://orcid.org/0000-0001-8672-9465","observed_orcids":["https://orcid.org/0000-0001-8672-9465"]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tuire Tirkkonen","raw_affiliation_strings":["Department of Pharmacology, Drug Development, and Therapeutics, University of Turku, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Drug Development, and Therapeutics, University of Turku, Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022802779","display_name":"Tero J. Vahlberg","orcid":"https://orcid.org/0000-0002-4935-3056","observed_orcids":["https://orcid.org/0000-0002-4935-3056"]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tero Vahlberg","raw_affiliation_strings":["Department of Biostatistics, University of Turku, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Turku, Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105125841","display_name":"Kari Laine","orcid":"https://orcid.org/0009-0003-4124-7333","observed_orcids":["https://orcid.org/0009-0003-4124-7333"]},"institutions":[{"id":"https://openalex.org/I2801970007","display_name":"Turku University Hospital","ror":"https://ror.org/05dbzj528","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]},{"id":"https://openalex.org/I4210127022","display_name":"Varsinais-Suomen Sairaanhoitopiiri","ror":"https://ror.org/036bxpj43","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210127022"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Kari Laine","raw_affiliation_strings":["Clinical Pharmacology, TYKSLAB, Hospital District of Southwest Finland, Turku, Finland; Medbase Ltd, Turku, Finland","Clinical Pharmacology, TYKSLAB, Hospital District of Southwest Finland, Turku, Finland","Medbase Ltd, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, TYKSLAB, Hospital District of Southwest Finland, Turku, Finland; Medbase Ltd, Turku, Finland","institution_ids":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]},{"raw_affiliation_string":"Clinical Pharmacology, TYKSLAB, Hospital District of Southwest Finland, Turku, Finland","institution_ids":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]},{"raw_affiliation_string":"Medbase Ltd, Turku, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5077170941"],"corresponding_institution_ids":["https://openalex.org/I155660961"],"apc_list":{"value":2085,"currency":"GBP","value_usd":2557},"apc_paid":null,"fwci":5.0779,"has_fulltext":true,"cited_by_count":66,"citation_normalized_percentile":{"value":0.95772607,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"41","issue":"8","first_page":"619","last_page":"628"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.635699987411499,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.635699987411499,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2003999948501587,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.08720000088214874,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.972000002861023},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.9909999966621399},{"id":"https://openalex.org/keywords/concomitant-medications","display_name":"concomitant medications","score":0.7839999794960022},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.824999988079071},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/antiplatelet-drugs","display_name":"antiplatelet agents","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.8339999914169312},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.9480700492858887},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8605527877807617},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.7871571779251099},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6358877420425415},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6258055567741394},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.5415665507316589},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49842262268066406},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.4799342751502991},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43936699628829956},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30921030044555664},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.19948333501815796},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.17209219932556152},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0819811224937439},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005387","descriptor_name":"Finland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006785","descriptor_name":"Hospitals, University","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/07853890903186168","doi":"https://doi.org/10.1080/07853890903186168","is_oa":true,"landing_page_url":"https://doi.org/10.1080/07853890903186168","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/07853890903186168?needAccess=true","source":{"id":"https://openalex.org/S203391715","display_name":"Annals of Medicine","issn_l":"0785-3890","issn":["0785-3890","1365-2060"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Medicine","raw_type":"journal-article"},{"id":"pmid:19711211","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19711211","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/07853890903186168","doi":"https://doi.org/10.1080/07853890903186168","is_oa":true,"landing_page_url":"https://doi.org/10.1080/07853890903186168","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/07853890903186168?needAccess=true","source":{"id":"https://openalex.org/S203391715","display_name":"Annals of Medicine","issn_l":"0785-3890","issn":["0785-3890","1365-2060"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321726","display_name":"Suomen Kulttuurirahasto","ror":"https://ror.org/027xav248"},{"id":"https://openalex.org/F4320327286","display_name":"Turun Yliopistollinen Keskussairaala","ror":"https://ror.org/05dbzj528"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978773847.pdf","grobid_xml":"https://content.openalex.org/works/W1978773847.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1526182533","https://openalex.org/W1564937852","https://openalex.org/W1646315500","https://openalex.org/W1957588549","https://openalex.org/W1968215209","https://openalex.org/W1973736848","https://openalex.org/W1974852991","https://openalex.org/W1977435377","https://openalex.org/W2012757283","https://openalex.org/W2018849937","https://openalex.org/W2026589095","https://openalex.org/W2043396343","https://openalex.org/W2059665864","https://openalex.org/W2067481115","https://openalex.org/W2072055347","https://openalex.org/W2089399378","https://openalex.org/W2090877991","https://openalex.org/W2092902579","https://openalex.org/W2096219546","https://openalex.org/W2106444498","https://openalex.org/W2109142164","https://openalex.org/W2118910625","https://openalex.org/W2131690429","https://openalex.org/W2137903085","https://openalex.org/W2146136250","https://openalex.org/W2156613835","https://openalex.org/W2163142667","https://openalex.org/W4301153945"],"related_works":["https://openalex.org/W2584667656","https://openalex.org/W3029233381","https://openalex.org/W2038694079","https://openalex.org/W3136441191","https://openalex.org/W2028669408","https://openalex.org/W2079770170","https://openalex.org/W2119560438","https://openalex.org/W2106708343","https://openalex.org/W2067481115","https://openalex.org/W1757672718"],"abstract_inverted_index":{"BACKGROUND:":[0],"Bleeding":[1],"is":[2,153],"a":[3,84,88,111],"serious":[4],"adverse":[5],"drug":[6,27],"reaction":[7],"associated":[8,82,109,165],"with":[9,83,110,166],"warfarin":[10,26,167],"therapy,":[11],"often":[12],"induced":[13],"by":[14],"interacting":[15,51],"co-medication.":[16,52],"METHODS:":[17],"We":[18,146],"investigated":[19],"the":[20,135,162],"frequency":[21],"and":[22,79,96,123,155],"clinical":[23],"consequences":[24],"of":[25,32,36,43,45,87],"interactions":[28],"utilizing":[29],"medical":[30],"records":[31],"6,772":[33],"warfarin-treated":[34,46,151],"in-patients":[35,47,152],"Turku":[37],"University":[38],"Hospital.":[39],"RESULTS:":[40],"A":[41],"total":[42],"48%":[44],"were":[48,81,108],"exposed":[49],"to":[50,160],"Adjusted":[53],"odds":[54],"ratio":[55,131],"(OR)":[56],"for":[57,61,132],"bleeding":[58,85,114,133,163],"was":[59,140],"highest":[60],"cytochrome":[62],"P450":[63],"2C9":[64],"(CYP2C9)":[65],"inhibitors":[66,106],"(OR":[67,91,118],"3.6;":[68],"95%":[69,93,99,120,126],"confidence":[70],"interval":[71],"(CI)":[72],"2.4-5.6).":[73],"Non-selective":[74],"non-steroidal":[75],"anti-inflammatory":[76],"drugs":[77],"(NSAID)":[78],"coxibs":[80],"risk":[86,115,164],"similar":[89],"magnitude":[90],"2.6;":[92,119],"CI":[94,100,121,127,143],"1.6-4.2":[95],"OR":[97,124],"3.1;":[98],"1.4-6.7,":[101],"respectively).":[102,129],"Selective":[103],"serotonin":[104],"re-uptake":[105],"(SSRI)":[107],"remarkably":[112],"higher":[113],"than":[116],"non-SSRIs":[117],"1.5-4.3":[122],"1.2;":[125],"0.3-4.3,":[128],"Odds":[130],"in":[134,150],"platelet":[136],"aggregation":[137],"inhibitor":[138],"group":[139],"1.6":[141],"(95%":[142],"0.8-3.1).":[144],"CONCLUSION:":[145],"conclude":[147],"that":[148],"co-medication":[149],"common":[154],"should":[156],"be":[157],"carefully":[158],"evaluated":[159],"decrease":[161],"therapy.":[168]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}